Common epigenetic markers associated with food addiction have been identified.
MicroRNAs that should attack SARS-CoV-2, the virus that causes COVID-19, diminish with age, and due to chronic health problems. The findings shed light on why those who are older, and those with health conditions are more susceptible to coronavirus.
Rat model study reveals printer toner nanoparticles may change both genetic and metabolic profiles, making disease more likely.
Study implicates dysregulation of epigenetic mechanisms of both DNA methylation and microRNA activity, in addition to oxytocin to hypersexuality.
Researchers have developed a new method to transplant neural stem cells into mice without the need for lifelong anti-rejection medications.
A new fruit fly study reveals a simple genetic system is behind complex movements. The finding sheds light on motor control issues associated with neurodegenerative diseases.
A new study reports chronic nicotine exposure during pregnancy alters the genetics and dopamine neurons of newborns. The findings could help researchers develop a possible cure for nicotine addiction.
Researchers have identified two major groups of genes involved in mutations that result in an overproduction of tau. The findings could offer new avenues for treatments to slow the progression of dementia.
Researchers find evidence of cognitive issues and miRNA biomarkers, indicating brain injuries from concussions or head-to-head contact, in college football players. The findings indicated lasting damage caused by sports related concussions occur earlier than expected.
A new study reports microRNAs in the blood are altered as a result of sleep deprivation. Researchers used MiRNA alterations as a biomarker to determine cognitive performance following psychological stress and sleep loss.
Researchers have developed a new injectable gel that releases microRNAs into heart muscles, restarting the replication of existing caridomyocytes following a heart attack.
Researchers have identified a unique biomarker in the blood of people with Multiple Sclerosis. Using a simple blood test, researchers were able to identify those with MS and discriminate between people at different stages of the disease.
